» Authors » Ki Hoon Kim

Ki Hoon Kim

Explore the profile of Ki Hoon Kim including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 121
Citations 417
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim S, Min J, Kim S, Lee E, Lim Y, Shin H, et al.
J Clin Neurol . 2025 Mar; 21(2):131-136. PMID: 40065454
Background And Purpose: Treatments for neuromyelitis optica spectrum disorder (NMOSD) such as eculizumab, ravulizumab, satralizumab, and inebilizumab have significantly advanced relapse prevention, but they remain expensive. Rituximab is an off-label...
2.
Hyun J, Kim S, Moon J, Park N, Kang Y, Kim K, et al.
Neurol Neuroimmunol Neuroinflamm . 2025 Feb; 12(3):e200366. PMID: 40020215
Background And Objectives: Association of human leukocyte antigen (HLA) with anti-aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder (AQP4-IgG NMOSD) has been reported. However, this association in the Korean population has...
3.
Kim S, Gomes A, Schindler P, Hyun J, Kim K, Lee D, et al.
JAMA Neurol . 2024 Dec; 82(2):168-175. PMID: 39714824
Importance: The temporal dynamics of serum glial fibrillary acidic protein (sGFAP) and serum neurofilament light chain (sNfL) as biomarkers of disease activity for neuromyelitis optica spectrum disorder (NMOSD) remain underexplored....
4.
Kang Y, Kim K, Hyun J, Kim S, Kim H
Mult Scler Relat Disord . 2024 Sep; 91:105859. PMID: 39236649
Background: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is an inflammatory disease affecting the central nervous system that may require long-term immunotherapy in relapsing cases. While immunotherapies utilized in neuromyelitis optica...
5.
Kwon Y, Kim B, Kim J, Park K, Seo D, Kim H, et al.
JAMA Neurol . 2024 Sep; 81(10):1073-1084. PMID: 39226035
Importance: A proportion of people with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) have a relapsing disease course and persistent anti-myelin oligodendrocyte glycoprotein immunoglobulin G (MOG-IgG) seropositivity. Few studies have investigated...
6.
Kim M, Kim K, Lee S
Disabil Rehabil Assist Technol . 2024 Aug; :1-6. PMID: 39162349
This study investigated the effects of using the LiftCar-150 track-based stair-climbing robot on muscle activity, usability, and psychological anxiety. While stair-climbing robots enhance mobility for individuals with physical disabilities, existing...
7.
Kim S, Ahn B, Lee D, Kim K, Hyun J, Kim M, et al.
Int J Mol Sci . 2024 Jun; 25(12). PMID: 38928104
The diagnosis of brain metastases (BMs) in patients with lung cancer (LC) predominantly relies on magnetic resonance imaging (MRI), a method that is constrained by high costs and limited accessibility....
8.
Kim K, Chung Y, Min J, Han H, Kim S, Shin H, et al.
J Neurol Neurosurg Psychiatry . 2024 May; 95(12):1168-1175. PMID: 38777578
Background: The risk-benefit relationship of immunosuppressive therapies (ISTs) for elderly patients with neuromyelitis optica spectrum disorder (NMOSD) is not well established. This study aimed to investigate the safety and efficacy...
9.
Kim K, Park M, Park E, Gwak H, Kim S, Seo J, et al.
Neurology . 2024 Feb; 102(5):e209167. PMID: 38364192
Background And Objectives: Leptomeningeal metastases (LMs) are neoplasms that proliferate to membranes lining the brain and spinal cord. Intra-CSF methotrexate (MTX) chemotherapy is a prevalent treatment option. However, resultant long-term...
10.
Kim K, Seo H, Jin Y, Kim K
Health Phys . 2024 Jan; 126(4):196-206. PMID: 38289160
The International Commission on Radiological Protection recommended that the representative person concept should be used in radiation dose assessment of the general public to specify exposed individuals. The objective of...